Edwin P. Alyea . Dr

Dr. Edwin P. Alyea specialitas in tractando cancer sanguinis aegros qui medullam vel medullam transplantandi caulis ossei considerant. Postremis 20 annis in translatione progressiones substantiales factae sunt, quae melioribus eventibus consecuta sunt. Hae progressiones includunt facultatem dosages chemotherapy inferiora adhibendi ad minuendam toxicitatem in aegris, ac methodos reducendi verisimilitudinem relapsus. Novis medicamentis et technicis utendis studeo ut eventus meliores efficiant sequentes caulis cellae translationi propter malignitates sanguinis. Discrimen est cum aegris collaborare fines curationis eorum definire et optimum factu esse. Multos annos sequentes eorum traducere, dilexi laborantes et familias suas.

Certification Board

American Board of Internum Med, Oncology Medical

fellowship

Oncologia medica, Institutum Cancri Dana-Farber (Massachusetts), 1992-1995

sedes

Medicina interna, Brigham et Hospitalis Mulierum (Massachusetts), 1989-1992

Education

MD, Dux University, 1989

• Adultus medulla et Stem Cell Transplant
• Autologous Transplant
• Allogeneica Transplantatio
• Syngeneicum Transplant

• Hourigan, Christopher S., Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li, et al. “Impact of Conditioning Intensity of Allogeneic Transplantation for Acuti Myeloid Leukemia With Genomic Evidence of Residual Disease.” Clin J Oncol 38, no. 12 (April 20, 2020): 1273–83. https://doi.org/10.1200/JCO.19.03011.
• Soiffer, Robert J., Haesook T. Kim, Joseph McGuirk, Mitchell E. Horwitz, Laura Johnston, Mrinal M. Patnaik, Witold Rybka, et al. “Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.” Clin J Oncol 35, no. 36 (20 Decembris 2017): 4003–11. https://doi.org/10.1200/JCO.2017.75.8177.
• Liu, Hien Duong, Kwang Woo Ahn, Zhen-Huan Hu, Mehdi Hamadani, Taiga Nishihori, Baldeep Wirk, Amer Beitinjaneh, et al. “Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.” Sanguinis medullis Transplantatio 23, no. 5 (May 2017): 767–75. https://doi.org/10.1016/j.bbmt.2017.01.078.
• Scott, Bart L., Marcelo C. Pasquini, Brent R. Logan, Juan Wu, Steven M. Devine, David L. Porter, Richard T. Maziarz, et al. “Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.” Clin J Oncol 35, no. 11 (April 10, 2017): 1154–61. https://doi.org/10.1200/JCO.2016.70.7091.
• Shaffer, Brian C., Kwang Woo Ahn, Zhen-Huan Hu, Taiga Nishihori, Adriana K. Malone, David Valcárcel, Michael R. Grunwald, et al. “Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.” Clin J Oncol XXXIV, no. 34 ( 16 Iunii 1 ): 2016–1864. https://doi.org/71/JCO.10.1200.
• Devine, Steven M., Kouros Owzar, William Blum, Flora Mulkey, Richard M. Stone, Jack W. Hsu, Richard E. Champlin, et al. “Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.” Clin J Oncol 33, no. 35 (10 Decembris 2015): 4167–75. https://doi.org/10.1200/JCO.2015.62.7273.
• Jacobson, Caron A., Lixian Sun, Haesook T. Kim, Sean M. McDonough, Carol G. Reynolds, Michael Schowalter, John Koreth, et al. “Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease.” Sanguinis medullis Transplantatio 20, no. 5 (May 2014): 668–75. https://doi.org/10.1016/j.bbmt.2014.01.021.
• Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, et al. “Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial.” Sanguinem 122, no. 8 (22 Augusti 2013): 1510-17. https://doi.org/10.1182/sanguinis-2013-04-495895.
• Porcheray, Fabrice, David B. Miklos, Blair H. Floyd, Stefanie Sarantopoulos, Roberto Bellucci, Robert J. Soiffer, Joseph H. Antin, Edwin P. Alyea, Jerome Ritz, and Emmanuel Zorn. “Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.” translationi 92, no. 3 (August 15, 2011): 359–65. https://doi.org/10.1097/TP.0b013e3182244cc3.